Heart Rhythm 2009's VT/VF Summit Update serves as an update to 2008's popular VT/VF Summit.
Building upon the success of last year's sold-out VT/VF Summit at Heart Rhythm 2008, this year's VT/VF Summit Update, held on Friday, May 15, Boston Convention and Exhibition Center in Room 205, consists of three 90-minute sessions and one abstract session. Other VT/VF sessions will be featured on Friday and will be highlighted in the final program.
Many of the internationally renowned faculty have returned to participate in the VT/VF Summit Update, including: Hein J. Wellens, MD; Sumeet S. Chugh, MD; Andrew E. Epstein, MD, FHRS; J. Thomas Bigger, Jr., MD; Vivek Y. Reddy, MD; Jeremy N. Ruskin, MD and many more!
The VT/VF Summit Update will take place in Boston Convention and Exhibition Center in Room 205.
Session Titles, Friday, May 15, 2009:
- VT/VF Summit Update I: Sudden Cardiac Arrest - Epidemiology and Early Management
8:00 – 9:30 a.m. - VT/VF Summit Update II: Optimal Utilization of ICD Therapy
1:30 – 3:00 p.m. - VT/VF Summit Update III: VT Ablation - Current Problems and New Techniques
4:30 – 6:00 p.m.
VT01. VT/VF Summit Update: Sudden Cardiac Arrest - Epidemiology and Early Management
Friday, May 15, 2009, 8:00 am - 9:30 am
Chairs:
Hein J. Wellens, MD. University Hospital Maastricht, Maastricht, Netherlands
Sumeet S. Chugh, MD. Oregon Health & Science University, Portland, OR
Who Are the Victims of SCA in 2009?
Peter J. Kudenchuk, MD, FHRS, CCDS. University of Washington Medical Center, Seattle, WA
How Genetics Influence Sudden Death Risk?
Dan M. Roden, MD. Vanderbilt University School of Medicine, Nashville, TN
Strategies to Improve Survival after SCA (Focus on Resuscitation Changes, Cooling, Brain/Heart Preservation, etc)
TBD
Optimal Use of AEDs (Focus on Public and Home Use, Legal Implications, etc)
Mark S. Link, MD. Tufts Medical Center, Boston, MA
Social, Environmental and Psychological Triggers for SCA
Christine M. Albert, MD. Brigham and Women's Hospital, Boston, MA
VT02. VT/VF Summit Update: Optimal Utilization of ICD Therapy
Friday, May 15, 2009, 1:30 pm - 3:00 pm
Chairs:
Andrew E. Epstein, MD, FHRS. University of Alabama at Birmingham, Birmingham, AL
J. Thomas Bigger, Jr., MD. Columbia University, New Rochelle, NY
Identifying Candidates for Primary Prevention of Sudden Death: Old and New Approaches
Henry R. Halperin, MD. Johns Hopkins Hospital, Baltimore, MD
Preventing and Managing Complications During ICD Therapy
Mark A. Wood, MD, FHRS. Virginia Commonwealth University, Richmond, VA
Unresolved Issues in ICD Therapy (Comorbidities, Age, Drug Therapy, Gender Racial Imbalances, etc)
John P. DiMarco, MD, PhD, FHRS. University of Virginia Health Sciences Center, Charlottesville, VA
Are Expanded Indications for ICD Therapy Needed? (Diastolic HF, ESRD, Scar Burden, etc)
Roger Freedman, MD, FHRS, CCDS. University of Utah, Salt Lake City, UT
Applying Guidelines in Everyday Practice
TBD
VT03. VT/VF Summit Update: VT Ablation - Current Problems and New Techniques
Friday, May 15, 2009, 4:30 pm - 6:00 pm
Chairs
Vivek Y. Reddy, MD. University of Miami, Miami, FL
Jeremy N. Ruskin, MD. Massachusetts General Hospital, Boston, MA
Endo/Epi VT
William G. Stevenson, MD, FHRS. Brigham and Women's Hospital, Boston, MA
Papillary Muscle
G. Neal Kay, MD. University of Alabama At Birmingham, Birmingham, AL
Hemodynamically Unstable VT
Paolo Della Bella, MD. Centro Cardiologico Monzino, Milano, Italy
